Citius Oncology, Inc.

NASDAQ: CTOR · Healthcare · Drug Manufacturers - General

PublicHQ New York City, NY · New YorkCIK 0001851484Reports USD

#1 of 1,394 Healthcare companies by revenue

EA Score

——

FH 57DQ —GM —SS 49

v0.1 · 35/100 weight · pillars only

↑ workforce scale, Piotroski F · ↓ listing tenure, filing timeliness

Methodology →

Revenue TTM

$5.6M

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

-$24.8M

Employees

285

Market cap

$63.3M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Net income-$24.8M-$24.8M2025

Operating income-$23.5M-$23.5M2025

Total assets$100.9M$100.9M2025

Liabilities$56.1M$56.1M2025

Equity$44.9M$44.9M2025

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Citius Oncology, Inc. earned -$24.8M in FY2025 net income.

Peers · Healthcare

Cibus, Inc.43D Clene Inc.27D OnKure Therapeutics, Inc.44D Hemab Therapeutics Holdings, Inc. Common Stock——

Neighbors

New York →

JPMorgan Chase & Co.$182.4B72B Morgan Stanley$34.3B60C The Goldman Sachs Group, Inc.——Philip Morris International Inc.$40.6B86A American Express Company$41.3B78B+Citigroup Inc.$85.2B56C

Key facts

CEOLeonard L. Mazur

SectorHealthcare

IndustryDrug Manufacturers - General

HeadquartersNew York City, NY

ExchangeNASDAQ: CTOR

Employees285

IPO date2022-12-08

Latest filings

8-K2026-06-01 10-Q2026-05-15 8-K2026-05-15 8-K2026-05-06 8-K2026-04-29 8-K2026-04-28 8-K2026-03-31 8-K2026-03-10

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.